Literature DB >> 15253646

Development of a protein chip: a MS-based method for quantitation of protein expression and modification levels using an immunoaffinity approach.

Erin N Warren1, Phillip J Elms, Carol E Parker, Christoph H Borchers.   

Abstract

Protein chip technology permits analysis of the expression and modification status of numerous targeted proteins within a single experiment, mainly through the use of antibody-based microarrays. Despite recent improvements in these protein chips, their applications are still limited for a variety of reasons, which include technical challenges in fabrication of the antibody chips as well as the very low specificity achieved by current detection methods. We have developed a unique approach for relative and/or absolute quantitation of protein expression and modification based on the capture of epitope peptides on affinity beads, which can be used to develop a mass-spectrometry-based protein chip technology. This new method, which utilizes antibodies immobilized on beads for the capture of target peptides, instead of proteins, eliminates many of the problems previously associated with protein chips. We present here several proof-of-principle experiments examining model peptides by this technique. These experiments show that the method is capable of (i). detecting peptides bound to a single antibody bead, (ii). detecting peptides at low (fmol) levels, (iii). producing MS/MS data of suitable quality for protein identification via database searching or de novo sequencing, (iv). quantitating peptides affinity-bound to antibody beads, (v). specifically detecting target peptides in complex mixtures over wide dynamic ranges, and (vi) is compatible with a microarray format for high-throughput analysis. Because our novel method uses antibody beads instead of a derivatized capture surface, and peptides instead of proteins for affinity capture, it can overcome many of the pitfalls of previous protein chip fabrications. Therefore, this method offers an improved approach to protein chip technology that should prove useful for diagnostics and drug development applications.

Mesh:

Substances:

Year:  2004        PMID: 15253646     DOI: 10.1021/ac049880g

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  4 in total

1.  Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension.

Authors:  Jennifer D Reid; Daniel T Holmes; D Randal Mason; Brinda Shah; Christoph H Borchers
Journal:  J Am Soc Mass Spectrom       Date:  2010-02-01       Impact factor: 3.109

2.  Optimal selection of epitopes for TXP-immunoaffinity mass spectrometry.

Authors:  Hannes Planatscher; Jochen Supper; Oliver Poetz; Dieter Stoll; Thomas Joos; Markus F Templin; Andreas Zell
Journal:  Algorithms Mol Biol       Date:  2010-06-25       Impact factor: 1.405

Review 3.  Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.

Authors:  Jeffrey R Whiteaker; Amanda G Paulovich
Journal:  Clin Lab Med       Date:  2011-09       Impact factor: 1.935

Review 4.  Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Authors:  Hussein Yassine; Chad R Borges; Matthew R Schaab; Dean Billheimer; Craig Stump; Peter Reaven; Serrine S Lau; Randall Nelson
Journal:  Proteomics Clin Appl       Date:  2013-07-09       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.